| panel_image_path,panel_caption |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339519_F4_panel0.png,Assessment of BMSCs proliferation across three groups using CCK-8 assay. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339519_F4_panel1.png,Quantitative comparison of migrated BMSCs in three groups at 24-h post-treatment. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339519_F4_panel2.png,Assessment of BMSCs migration across three groups using Transwell chamber assay. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339519_F4_panel3.png,"Assessment of BMSCs migration across three groups using Scratch wound healing assay for 2D group, CS-HCA hydrogel group, and CS-HCA@PLGA-PEG@KGN hydrogel group at 0h, 12h, and 24h." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339563_fig3_panel0.png,"Histological examination (hematoxylin and eosin stain, × 100) reveals a spindle cell tumor with a biphasic pattern, including hypercellular and hypocellular myxoid areas (Antoni A and Antoni B regions)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339563_fig3_panel1.png,"Immunohistochemical examination (× 400) shows strong positivity for S-100 protein in the tumor cells, supporting the diagnosis of a schwannoma." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339603_Fig1_panel0.png,A schematic illustration of the synthesis process for Pt-modified Bi2O3 and the fabrication of a gas sensor. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339603_Fig1_panel1.png,B - ESEM image showing the surface morphology of Pt-decorated Bi2O3 at a scale of 5 μm. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339603_Fig1_panel2.png,"C - ESEM image of Pt-decorated Bi2O3 at a higher magnification, revealing details at a scale of 500 nm." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339603_Fig1_panel3.png,"D - ESEM image of Pt-decorated Bi2O3 highlighting features at a scale of 200 nm, with a specific measurement of 170 nm indicated." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339603_Fig1_panel4.png,"E - ESEM image of Pt-decorated Bi2O3 at a scale of 100 nm, showing detailed surface characteristics." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339603_Fig1_panel5.png,"F - TEM image of Pt-decorated Bi2O3 at a scale of 500 nm, providing insight into its structure." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339603_Fig1_panel6.png,"G - TEM image of Pt-decorated Bi2O3 at a high resolution, showing lattice fringes and crystal planes." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339603_Fig1_panel7.png,"H - EDS elemental mapping of Pt-decorated Bi2O3, showing the distribution of elements at a scale of 1 μm." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339603_Fig1_panel8.png,I - EDS elemental mapping of Bi in Pt-decorated Bi2O3. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339603_Fig1_panel9.png,J - EDS elemental mapping of O in Pt-decorated Bi2O3. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339603_Fig1_panel10.png,K - EDS elemental mapping of Pt in Pt-decorated Bi2O3. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339623_Fig1_panel0.png,Fundus photographs showing the right eye (OD) on the left and the left eye (OS) on the right. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339623_Fig1_panel1.png,Fluorescein fundus angiography (FA) images displaying the right eye (OD) on the left and the left eye (OS) on the right. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339623_Fig1_panel2.png,"Optical coherence tomography (OCT) images revealing disruption of the ellipsoid zone (EZ) in both eyes, with a hyper-refractive nodule at the RPE line in the left eye (OS) indicated by the white arrow." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339623_Fig1_panel3.png,Goldmann kinetic perimetry results for the left eye (OS) on the left and the right eye (OD) on the right. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339623_Fig1_panel4.png,"Flash electroretinography (ERG) results showing oscillatory potentials extinguished in both eyes, marked by the black arrow." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339627_Fig3_panel0.png,"Typical fundus of a shorter AL eye (actual AL: 22.48 mm, predicted AL: 23.46 mm)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339627_Fig3_panel1.png,"Typical fundus of a longer AL eye (actual AL: 25.12 mm, predicted AL: 25.16 mm)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339627_Fig3_panel2.png,"Atypical fundus of a shorter AL eye with myopic fundus changes (actual AL: 20.95 mm, predicted AL: 22.93 mm)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339627_Fig3_panel3.png,"Atypical fundus of a longer AL eye with few myopic fundus changes (actual AL: 25.37 mm, predicted AL: 23.81 mm)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339643_Fig1_panel0.png,"CT scans of the pancreas at three different stages: 3 months before onset, at onset, and 6 months after onset. No significant morphological changes are observed." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339643_Fig1_panel1.png,Magnetic resonance cholangiopancreatography (MRCP) scan at the onset showing no enlargement or interruption of the main pancreatic duct. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339643_Fig1_panel2.png,"Diffusion-weighted imaging (DWI) scan with a low b-value at onset, showing high-intensity signals in the pancreas." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339643_Fig1_panel3.png,"Diffusion-weighted imaging (DWI) scan with a high b-value at onset, showing high-intensity signals in the pancreas." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339643_Fig1_panel4.png,"Apparent diffusion coefficient (ADC) map at onset, showing low ADC values in the pancreas." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339643_Fig1_panel5.png,"Diffusion-weighted imaging (DWI) scan with a high b-value 3 months after onset, showing a reduction in high-intensity signals compared to the onset." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339651_Fig2_panel0.png,"H&E staining highlights 7N neurons through anatomical identification, with arrowheads pointing to specific cells." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339651_Fig2_panel1.png,"ChAT-ir cytoplasm and fibers in motor neurons within the 7N, with arrowheads indicating positive immunoreactivity, some corresponding to the same cells as in the H&E panel." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339651_Fig2_panel2.png,"TH-ir cytoplasm and fibers in catecholaminergic C1 neurons, with arrowheads marking areas of positive immunoreactivity." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339651_Fig2_panel3.png,"Phox2b-ir nuclei in NTS neurons, with arrowheads pointing out positively stained nuclei." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339651_Fig2_panel4.png,"PACAP-ir cytoplasm and fibers of hematoxylin counterstained NTS neurons, with arrowheads highlighting regions of immunoreactivity." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339651_Fig2_panel5.png,"Galanin-ir cytoplasm and fibers in the NTS, with arrowheads indicating areas of positive immunostaining." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339655_Fig6_panel0.png,Type 2 MNV. Fundus photo shows a gray-white lesion with hemorrhage and fibrinous exudates (arrowhead). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339655_Fig6_panel1.png,Early-phase FA shows hyperfluorescence indicating MNV. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339655_Fig6_panel2.png,Late-phase ICGA shows hyperfluorescence indicating MNV. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339655_Fig6_panel3.png,OCT corresponding to the dashed arrow in (a) shows subretinal hyperreflective material under the retina. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339655_Fig6_panel4.png,"En face OCTA image from the outer retina to the choriocapillaris, corresponding to the area indicated by the white square in (c), shows MNV." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339728_Fig9_panel0.png,"Wound healing images of MDA-MB-231 cells at 0 h and 24 h post-transfection with sh-ctrl, sh-LRP8-1#, and sh-LRP8-2#." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339728_Fig9_panel1.png,Bar graph showing the wound area percentage at 24 h compared to baseline measurements at 0 h for MDA-MB-231 cells. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339728_Fig9_panel2.png,"Wound healing images of BT549 cells at 0 h and 24 h post-transfection with sh-ctrl, sh-LRP8-1#, and sh-LRP8-2#." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339728_Fig9_panel3.png,Bar graph showing the wound area percentage at 24 h compared to baseline measurements at 0 h for BT549 cells. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339728_Fig9_panel4.png,"Transwell migration and invasion assay images of BT549 cells post-transfection with sh-ctrl, sh-LRP8-1#, and sh-LRP8-2#." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339728_Fig9_panel5.png,Bar graph showing the number of migrated cells in BT549 cells post-transfection. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339728_Fig9_panel6.png,Bar graph showing the number of invaded cells in BT549 cells post-transfection. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339808_F0001_panel0.png,Low-grade tubular adenoma stained with haematoxylin and eosin at ×40 magnification. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339808_F0001_panel1.png,High-grade tubular adenoma stained with haematoxylin and eosin at ×40 magnification. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339808_F0001_panel2.png,Low-grade tubulovillous adenoma stained with haematoxylin and eosin at ×100 magnification. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339808_F0001_panel3.png,Cyclooxygenase-2 positive control (renal tubules) at ×400 magnification. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339808_F0001_panel4.png,Cyclooxygenase-2 positive staining in a low-grade tubular adenoma at ×100 magnification. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339808_F0001_panel5.png,Cyclooxygenase-2 negative staining in a low-grade tubular adenoma at ×100 magnification. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339843_Fig2_panel0.png,"Graphical representation of signs and symptoms of breast cancer, including various visual indicators such as lumps, nipple changes, skin texture alterations, and pain." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339846_Fig1_panel0.png,"A four-lumen double-balloon catheter is shown. The tip hole (1st lumen) is visible on the left, the side hole (2nd lumen) is in the middle, and the distal balloon (3rd lumen) and proximal balloon (4th lumen) are inflated and labeled." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339905_fsn370736-fig-0002_panel0.png,Effects of TP on body weight over weeks in aged T2DM model rats. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339905_fsn370736-fig-0002_panel1.png,Comparison of food intake before and after STZ injection in different groups of aged T2DM model rats. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339905_fsn370736-fig-0002_panel2.png,Changes in 24-hour urine volume before and after 8 weeks of intervention in various groups of aged T2DM model rats. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339905_fsn370736-fig-0002_panel3.png,Comparison of 24-hour water intake before and after 8 weeks of intervention in different groups of aged T2DM model rats. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339905_fsn370736-fig-0002_panel4.png,Representative SA-β-gal staining images in kidney tissues of rats from different groups (100×). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339905_fsn370736-fig-0002_panel5.png,Quantitative analysis of the area of SA-β-gal staining positive cells in kidney tissues of rats from different groups. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339905_fsn370736-fig-0002_panel6.png,Representative HE images of islet vacuoles in different groups of rats (200×). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339905_fsn370736-fig-0002_panel7.png,Quantitative analysis of the islet vacuoles ratio to cells in different groups of rats. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339905_fsn370736-fig-0002_panel8.png,Changes in fasting blood glucose levels over weeks in different groups of aged T2DM model rats. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339905_fsn370736-fig-0002_panel9.png,"Representative Western Blot images for P21, P53, and P-IRS1 expression in different groups of rats." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339905_fsn370736-fig-0002_panel10.png,Quantification of P21 expression in different groups of rats. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339905_fsn370736-fig-0002_panel11.png,Quantification of P53 expression in different groups of rats. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339905_fsn370736-fig-0002_panel12.png,Quantification of P-IRS1 expression in different groups of rats. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339906_cns70559-fig-0005_panel0.png,"Neurological scores of rats in each group (n= 9), showing the effects of different treatments on neurological deficit scores." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339906_cns70559-fig-0005_panel1.png,"TTC staining of brain sections from rats treated with various doses of Gas, NBP, or left untreated, illustrating brain infarct areas." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339906_cns70559-fig-0005_panel2.png,"Quantitative analysis of brain infarct volume (%), comparing the effects of different treatments on infarct size in rats." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339906_cns70559-fig-0005_panel3.png,"Representative HE staining images of brain sections from rats treated with or without Gas, showing morphological changes in the brain." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339906_cns70559-fig-0005_panel4.png,Quantitative analysis of relative neuronal densities in the CA1 region of MCAO/R rats treated with different doses of Gas or NBP. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339906_cns70559-fig-0005_panel5.png,Quantitative analysis of relative neuronal densities in the cortex of MCAO/R rats treated with different doses of Gas or NBP. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339906_cns70559-fig-0005_panel6.png,Quantitative analysis of relative neuronal densities in the CA3 region of MCAO/R rats treated with different doses of Gas or NBP. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339906_cns70559-fig-0005_panel7.png,RT-PCR analysis of IL-1β mRNA expression levels in brain regions of MCAO/R rats treated with different doses of Gas or NBP. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339906_cns70559-fig-0005_panel8.png,RT-PCR analysis of TNF-α mRNA expression levels in brain regions of MCAO/R rats treated with different doses of Gas or NBP. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339906_cns70559-fig-0005_panel9.png,RT-PCR analysis of IL-6 mRNA expression levels in brain regions of MCAO/R rats treated with different doses of Gas or NBP. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339918_Fig6_panel0.png,"Representative images of CA-IX staining under different conditions (Ctrl, NP, 4Gy, radioPDT). Scale bar, 100 µm." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339918_Fig6_panel1.png,"Relative level of CA-IX staining measured by ImageJ and analyzed by One-way ANOVA for Ctrl, NP, 4Gy, and radioPDT groups (mean ± SEM; n = 5 mice/group)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339926_Fig11_panel0.png,Schematic diagram showing a transparent circle with three dark spots representing Nisin detection in S1 fermentation broth. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel0.png,Image A1 showing HER2 IHC slide interpreted as score 0 at 20× magnification. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel1.png,"Image A2 showing the predicted probability map for IBC areas in A1, with red indicating high probability." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel2.png,"Image A3 showing the binarized segmentation mask of IBC regions from A2, with white representing IBC areas." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel3.png,"Image A4 showing the nucleus detection probability map for A1, with white dots indicating nucleus centroids." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel4.png,"Image A5 showing the integrated result of IBC segmentation and nucleus detection for A1, with red marking tumor cell nuclei." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel5.png,Image B1 showing HER2 IHC slide interpreted as score 0 at 40× magnification. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel6.png,"Image B2 showing the predicted probability map for IBC areas in B1, with red indicating high probability." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel7.png,"Image B3 showing the binarized segmentation mask of IBC regions from B2, with white representing IBC areas." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel8.png,"Image B4 showing the nucleus detection probability map for B1, with white dots indicating nucleus centroids." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel9.png,"Image B5 showing the integrated result of IBC segmentation and nucleus detection for B1, with red marking tumor cell nuclei." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel10.png,Image C1 showing HER2 IHC slide interpreted as score 1+ at 20× magnification. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel11.png,"Image C2 showing the predicted probability map for IBC areas in C1, with red indicating high probability." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel12.png,"Image C3 showing the binarized segmentation mask of IBC regions from C2, with white representing IBC areas." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel13.png,"Image C4 showing the nucleus detection probability map for C1, with white dots indicating nucleus centroids." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel14.png,"Image C5 showing the integrated result of IBC segmentation and nucleus detection for C1, with red marking tumor cell nuclei." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel15.png,Image D1 showing HER2 IHC slide interpreted as score 1+ at 40× magnification. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel16.png,"Image D2 showing the predicted probability map for IBC areas in D1, with red indicating high probability." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel17.png,"Image D3 showing the binarized segmentation mask of IBC regions from D2, with white representing IBC areas." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel18.png,"Image D4 showing the nucleus detection probability map for D1, with white dots indicating nucleus centroids." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12339971_Fig2_panel19.png,"Image D5 showing the integrated result of IBC segmentation and nucleus detection for D1, with red marking tumor cell nuclei." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340079_Fig3_panel0.png,"Electrophoretic pattern of IPCR products from PBLs of a patient with smoldering type ATL before and after separation using the magnetic cell sorting method. Lane labels include M for size markers, and lanes 1 through 5 represent different sample types." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340079_Fig3_panel1.png,Results of Southern blot analysis of IPCR products from SF-25-positive and SF-25-negative cells. Lanes 1 through 5 correspond to various samples including controls and separated cell populations. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340083_Fig4_panel0.png,AOS image of an untreated sample showing initial AOS values. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340083_Fig4_panel1.png,"AOS image after treatment with anti-Ki67 only, showing reduced AOS values." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340083_Fig4_panel2.png,"AOS image after treatment with anti-Ki67 followed by immunostaining with DAB, retaining high AOS values." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340083_Fig4_panel3.png,"AOS image of the untreated sample after actinase digestion, showing significant AOS value reduction." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340083_Fig4_panel4.png,"AOS image of the sample treated with anti-Ki67 only after actinase digestion, showing similar AOS value reduction as the untreated sample." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340083_Fig4_panel5.png,"AOS image of the sample treated with anti-Ki67 and DAB after actinase digestion, showing retention of high AOS values." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340083_Fig4_panel6.png,HE-stained light microscopy image of the metastatic carcinoma before digestion. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340083_Fig4_panel7.png,"Light microscopy image corresponding to the AOS image, showing lymphocytes." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340083_Fig4_panel8.png,"Magnified light microscopy image highlighting the area with high AOS values, corresponding to lymphocytes." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340083_Fig4_panel9.png,"HE-stained light microscopy image of the metastatic carcinoma before digestion, showing the tumor area." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340083_Fig4_panel10.png,"Magnified light microscopy image of the HE-stained sample, showing detailed cellular structures." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340173_aos17485-fig-0001_panel0.png,"Example (a) showing small schisis cavities in the inner nuclear layer. The left column displays an unannotated slice, the middle column shows human grader annotation, and the right column presents AI model segmentation with a Dice coefficient of 0.8072." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340173_aos17485-fig-0001_panel1.png,"Example (b) illustrating extensive schisis cavities in the inner nuclear and outer plexiform layers, with vessel shadowing temporally mimicking schisis cavities in the outer nuclear layer. The AI model correctly avoids segmented schisis areas in the shadowed region but misses small areas in the outer plexiform layer nasally, as shown in the three columns for unannotated slice, human grader annotation, and AI model segmentation with a Dice coefficient of 0.8193." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340173_aos17485-fig-0001_panel2.png,"Example (c) depicting schisis cavities in multiple layers including the ganglion cell layer, inner nuclear layer, and outer nuclear layer. There is some outer retinal atrophy with a schisis cavity extending into the outer nuclear layer, which is accurately segmented by the AI model, as demonstrated in the unannotated slice, human grader annotation, and AI model segmentation with a Dice coefficient of 0.8467." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340188_fig6-25158414251362010_panel0.png,Optical Coherence Tomography (OCT) image highlighting the allograft bio-scaffold with a green square indicating the area of focus on the cyclodialysis. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340188_fig6-25158414251362010_panel1.png,"Close-up OCT image of the internal filtration conduit within the allograft bio-scaffold, showcasing the detailed structure and reinforcement." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340285_f3_panel0.png,Simple chest radiography showing a cervical rib on the left side. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340285_f3_panel1.png,Coronal view of CT showing a cervical rib compressing the subclavian artery. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340285_f3_panel2.png,T1-weighted MRI showing a cervical rib on the left side. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340285_f3_panel3.png,Simple chest radiography showing a prominent first rib on the right side. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340285_f3_panel4.png,Coronal view of CT showing fusion of the first and second ribs on the left side. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340285_f3_panel5.png,T1-weighted MRI showing fusion of the first and second ribs on the left side. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340291_f7_panel0.png,Pre- and postoperative 3D-EIT and CTPA images in a patient with pulmonary embolism undergoing percutaneous left pulmonary artery thrombectomy with intraventricular thrombolysis. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340291_f7_panel1.png,Pre- and post-treatment 3D-EIT and CTPA images in a patient with bilateral pulmonary embolism receiving intravenous thrombolysis. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340291_f7_panel2.png,"Pre- and post-treatment 3D-EIT, CTPA, and perfusion scan images in a patient with left pulmonary embolism undergoing percutaneous pulmonary thrombolysis." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340299_FIG4_panel0.png,Coronal image of a trial being inserted. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340299_FIG4_panel1.png,Axial image of a trial being inserted. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340299_FIG4_panel2.png,Sagittal image of a trial being inserted. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340299_FIG4_panel3.png,Coronal image of a cage being inserted. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340299_FIG4_panel4.png,Axial image of a cage being inserted. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340299_FIG4_panel5.png,Sagittal image of a cage being inserted. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340358_fig2-15330338251365334_panel0.png,Diagnostic PET/CT image of Patient A with liver cancer. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340358_fig2-15330338251365334_panel1.png,Emulated X1 PET image overlaid on diagnostic CT for Patient A with liver cancer. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340358_fig2-15330338251365334_panel2.png,Diagnostic PET/CT image of Patient B showing a PET-avid left supraclavicular node. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340358_fig2-15330338251365334_panel3.png,Emulated X1 PET image overlaid on diagnostic CT for Patient B with a PET-avid left supraclavicular node. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340358_fig2-15330338251365334_panel4.png,Diagnostic PET/CT image of Patient C with a lesion in the superior mesenteric artery. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340358_fig2-15330338251365334_panel5.png,Emulated X1 PET image overlaid on diagnostic CT for Patient C with a lesion in the superior mesenteric artery. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340388_fig3_panel0.png,SDS-PAGE of collagen extracted from cartilage produced by wild-type or Arg719Cys procollagen-II expressing cells at day 44. The gel shows a reduction in electrophoretic mobility for Arg719Cys collagen-II compared to wild-type. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340388_fig3_panel1.png,"Confocal imaging of chondronoid sections immunostained against collagen-II and the ER marker calreticulin (Calr) at day 44. The images reveal intracellularly retained procollagen-II in the disease variant, with reduced mobility and altered staining patterns compared to wild-type." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340388_fig3_panel2.png,Blinded quantification suggests that Arg719Cys procollagen-II-expressing cells may contain more intracellular procollagen-II than wild-type. The graph shows a significant increase in the percentage of cells with intracellular collagen-II in the mutant variant. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340388_fig3_panel3.png,"Transmission electron microscopy (TEM) at day 44 shows distended ER in cells expressing Arg719Cys procollagen-II, marked with yellow asterisks. The images highlight structural differences between wild-type and mutant cells at different magnifications." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340406_F2_panel0.png,Graph showing relative expression of circFryl in different conditions. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340406_F2_panel1.png,Ultrasound images comparing sham and model groups with various treatments. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340406_F2_panel2.png,Histological images showing tissue differences between sham and model groups under different treatments. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340406_F2_panel3.png,"Western blot analysis of COI-1, COI-3, α-SMA, MMP9, and β-actin in different conditions." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340406_F2_panel4.png,Immunofluorescence staining for α-SMA in sham and model groups with various treatments. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340406_F2_panel5.png,"Western blot analysis of Bcl-2, BAX, Cleaved-Caspase-3, Caspase-3, and β-actin in different conditions." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340467_FIG5_panel0.png,MRI scan (A) showing basi-parallel anatomical scanning of the basilar artery (BA). The proximal part of BA is indicated by the blue arrows. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340467_FIG5_panel1.png,"Heavy T2-weighted image (B) showing the proximal part of the basilar artery (BA) with an outer diameter of 3.0 mm, indicated by the blue arrow." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340467_FIG5_panel2.png,"Heavy T2-weighted image (C) showing the stenosed part of the basilar artery (BA) with an outer diameter of 1.9 mm, indicated by the blue arrowhead." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340467_FIG5_panel3.png,"Heavy T2-weighted image (D) showing the distal part of the basilar artery (BA) with an outer diameter of 3.8 mm, indicated by the blue arrow." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340480_f3-ol-30-4-15216_panel0.png,"Cancer cells growing in an adenoid infiltrative manner, with the interstitial tissue promoting fibroblast proliferation (magnification, ×200)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340480_f3-ol-30-4-15216_panel1.png,"Tumor invading the submucosal layer, presenting as irregular glandular or sieve-like structures (magnification, ×200)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340480_f3-ol-30-4-15216_panel2.png,"Low-magnification view showing cancer cells exhibiting irregular adenoid infiltrative growth, with increased interstitial fibrosis. The cells are multi-layered, have large and deeply stained nuclei, some of which are vacuolated showing significant atypia, and nuclear division figures can be observed (magnification, ×100)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340480_f3-ol-30-4-15216_panel3.png,"Low-magnification field demonstrating similar cytological features (magnification, ×100)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340514_f0010_panel0.png,A. Second laryngoscopy (February 2025) revealing significant enlargement of the cyst-like lesions in the epiglottic fold. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340514_f0010_panel1.png,B. Alternative angle showing the other lesion and patent airway. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340536_F6_panel0.png,"Dorsal view of Tekellinazhangziqingisp. nov., female paratype. Scale bar: 0.2 mm." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340536_F6_panel1.png,"Ventral view of Tekellinazhangziqingisp. nov., female paratype. Scale bar: 0.2 mm." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340536_F6_panel2.png,"Detail of vulva, ventral view of Tekellinazhangziqingisp. nov., female paratype. Scale bar: 0.05 mm." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340552_F1_panel0.png,"DaTSCAN SPECT normal, showing symmetrical ligand binding in both putamina and caudate nuclei." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340552_F1_panel1.png,"Patient 1: Ligand binding is almost absent in both putamina, with markedly and symmetrically reduced uptake in the caudate nucleus bilaterally." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340552_F1_panel2.png,"Patient 2: DaTSCAN SPECT shows considerably decreased ligand binding in both putamina, with initial uptake reduction observed in the right caudate." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340575_dev70071-fig-0002_panel0.png,"Thermal image highlighting various facial ROIs for infant temperature extraction, including forehead, periorbital area, nasal tip, cheek, chin, and maxillary area." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340668_F8_panel0.png,"Panel A shows a section of the spinal cord from a WT littermate, immunostained for TRIM2. Motor and sensory neurons, indicated by arrows, exhibit strong TRIM2 positivity. The dotted line marks the boundary between gray and white matter." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340668_F8_panel1.png,"Panel B displays a section of the spinal cord from an 8-week-old Trim2A/A mouse. Unlike the WT sample, the motor and sensory neurons show weak or no TRIM2 staining. The dotted line delineates the gray and white matter regions." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340668_F8_panel2.png,"Panel C presents a section of the DRG from a WT littermate. Strong TRIM2 expression is observed in the sensory neurons, as highlighted by the arrows." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340668_F8_panel3.png,Panel D illustrates a section of the DRG from an 8-week-old Trim2A/A mouse. The sensory neurons lack significant TRIM2 staining compared to the WT sample. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340668_F8_panel4.png,"Panel E shows a semi-thin section of sensory neurons in the DRG from a 26-week-old Trim2A/A mouse. The neurons appear relatively normal, with no significant abnormalities noted." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340668_F8_panel5.png,"Panel F depicts a semi-thin section of the ventral root from a 26-week-old Trim2A/A mouse. An arrow points to a degenerating myelinated axon, indicating some abnormality in this region." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340668_F8_panel6.png,"Panel G presents a semi-thin section of the dorsal root from a 26-week-old Trim2A/A mouse. The neurons appear mostly normal, with no significant degenerative changes observed." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340694_f2-apm-24155_panel0.png,"Positron emission tomography shows increased fluorodeoxyglucose uptake along the left brachial plexus and axillary lymph nodes, indicating potential metastasis." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340705_cre270193-fig-0002_panel0.png,"Radiographic view showing an implant with labeled points for MBL measurement. Point b marks the apical end of the implant, while points b1 and b2 indicate the apical ends on the mesial and distal sides. Point a is the central point of the implant shoulder, and points a1 and a2 show the initial bone contact points on the mesial and distal sides." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340796_F4_panel0.png,"Reconstruction of the DBS electrodes implanted in the bilateral NAcc to treat anorexia on a 3D coronal view of an MNI template brain, with the NAcc core and shell presented in light blue and dark blue, respectively." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340796_F4_panel1.png,"Win-stay analyses showing a decrease in the relationship between reward and subsequent win-stay behaviors after DBS-NAcc. Each dot represents an individual participant’s mean beta estimate for a block and the specified condition, with the shaded area representing the standard deviation around the mean." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340796_F4_panel2.png,"Learning curves associated with the high probability option across the whole session (four reversal periods). The curves show the percentage choice of the HP symbol for DBS-OFF, DBS-ON, and Healthy SHAM conditions, with a 5-trial running average applied to smooth trial-by-trial variability." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340808_F5_panel0.png,Expression of CCR2 and CX3CR1YFP in the blood-circulating recruited Mo/Mo-M in the lower spiral ligament and neuronal region after noise exposure. Insets show higher magnification of CCR2- and CX3CR1YFP-expressing cells. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340808_F5_panel1.png,"Expression of Ly6C and CX3CR1YFP in the blood-circulating recruited Mo/Mo-M in the lower spiral ligament and neuronal region after noise exposure. Note the presence of Ly6C in the RM in the spiral ganglion, possibly indicating an early inflammatory response." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340819_F7_panel0.png,Objective function for oscillatory dynamics in ligand expression at opposite extremes of the external morphogen gradient E1. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340819_F7_panel1.png,Signaling pathway corresponding to the objective of oscillatory dynamics in ligand expression. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340819_F7_panel2.png,Concentration of the stable external morphogen gradient E1 and the intracellular expression and extracellular concentration of diffusible ligands L1 and L2 across an 8x8 field of cells over time. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340829_F5_panel0.png,"TTLL10-SNAP(Alexa647) (cyan) association with various types of microtubules: unmodified, monoglycylated, monoglycylated/polyglutamylated, polyglycylated, and polyglycylated/polyglutamylated. Microtubules are labeled with HiLyte 488 (magenta) or outlined in yellow. Scale bar, 5 μm." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340829_F5_panel1.png,"Quantification of TTLL10-SNAP(Alexa647) recruitment to modified microtubules, normalized to unmodified microtubules. Data points represent individual measurements, with error bars indicating standard deviation. Statistical significance is indicated by p-values (**** p < 0.0001)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340854_F3_panel0.png,Representative fluorescent images of wild type spheroids labeled with DAPI (nuclei) and Ki-67 (G1/S/G2/M phases of the cell cycle) as a function of spheroid size. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340854_F3_panel1.png,Representative fluorescent images of TMZ-resistant spheroids labeled with DAPI (nuclei) and Ki-67 (G1/S/G2/M phases of the cell cycle) as a function of spheroid size. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340854_F3_panel2.png,Representative fluorescent images of wild type spheroids labeled with Calcein-AM (live cells) and bobo-3 iodide (dead cells) as a function of spheroid size. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340854_F3_panel3.png,Representative fluorescent images of TMZ-resistant spheroids labeled with Calcein-AM (live cells) and bobo-3 iodide (dead cells) as a function of spheroid size. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340856_F2_panel0.png,"Panel A shows the delocalization of mCherry-GIfT2 by the depletion of Ag85A in M. smegmatis. It includes images of IMD protein localization with and without Ag85A, a graph of fluorescent intensity across cell length, and a scatter plot comparing cap-to-side wall ratios." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340856_F2_panel1.png,"Panel B illustrates the fractionation of IMD and PM-CW after ultracentrifugation. It features a diagram of the density gradient and western blots analyzing PimB' and MptC as marker proteins for IMD and PM-CW fractions, respectively." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340902_F5_panel0.png,"Panel A: Unthresholded ENM map of sleep across different Z values, showing brain activity patterns related to sleep." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340902_F5_panel1.png,"Panel B: Thresholded ENM map of sleep after voxelwise FDR correction, highlighting significant brain regions associated with sleep." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340902_F5_panel2.png,"Panel C: Association between the sleep ENM map and various factors such as urbanicity, stress, greenspace, air pollution, income, and noise pollution, with correlation coefficients indicated for each relationship." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340908_F8_panel0.png,Dual IF analysis of M1Mφ marker CD40 (green) and blood vessel endothelium marker LAMA5 (red) for NTg and Tg+/-ATG13 samples. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340908_F8_panel1.png,Scatter histogram analyses of CD40-ir cells at a 10 μm radius from the outer wall of the blood vessel for NTg and Tg+/-ATG13 groups. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340908_F8_panel2.png,Dual IF analysis of M2Mφ marker CD206 (green) and LAMA5 (red) for NTg and Tg+/-ATG13 samples. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340908_F8_panel3.png,Scatter histogram analyses of CD206-ir cells at a 10 μm radius from the outer wall of the blood vessel for NTg and Tg+/-ATG13 groups. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340908_F8_panel4.png,LFB staining of myelin (lighter blue) in the muscle-serving nerve bundles counterstained with cresyl violet (deep blue) in the biceps femoris muscle of NTg and Tg+/-ATG13 mice. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340908_F8_panel5.png,3D surface plot identifying axonal fibers with less myelin integrity in NTg and Tg+/-ATG13 samples. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340921_F3_panel0.png,High-angle Annular Dark-field image of Ga-MIL-116@AgNPs with a scale bar of 200 nm. Inset shows the frequency histogram of AgNP cluster diameters adsorbed on the surface of Ga-MIL-116 MOFs. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340921_F3_panel1.png,Gallium elemental mapping of Ga-MIL-116@AgNPs with a scale bar of 200 nm. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340921_F3_panel2.png,Oxygen elemental mapping of Ga-MIL-116@AgNPs with a scale bar of 200 nm. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340921_F3_panel3.png,Silver elemental mapping of Ga-MIL-116@AgNPs with a scale bar of 200 nm. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340921_F3_panel4.png,Merge of the gallium and silver elemental signals for Ga-MIL-116@AgNPs with a scale bar of 200 nm. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340931_F0003_panel0.png,"Negative control: Normal human serum incubated with normal renal tissue, immunofluorescence for IgG." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340931_F0003_panel1.png,"Positive control: Serum from a confirmed anti-GBM disease patient incubated with normal renal tissue, immunofluorescence for IgG." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340931_F0003_panel2.png,"Patient’s serum incubated with normal renal tissue, immunofluorescence for IgG." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12340931_F0003_panel3.png,Blank control. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341149_Fig6_panel0.png,"Diagram illustrating CRISPR-mediated knockout of CK137956 in a −/− mouse and rescue schedule, showing mutant and rescue alleles with gene type sequences." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341149_Fig6_panel1.png,"Gel electrophoresis results for CRISPR cleavage efficiency test using C9 sg1, C9 sg2, and control samples." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341149_Fig6_panel2.png,"Microscopic images of CK137956−/− mouse testes and epididymides after CRISPR RNP rescue transfection, highlighting pathological cell pellets, sperm, and blocked round sperm." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341149_Fig6_panel3.png,"Images of CK137956−/− mice testicles before and after CRISPR RNP rescue transfection, indicating testicle rescue." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341149_Fig6_panel4.png,"ICSI cells of CK137956−/− CRISPR rescue sperm under microscopic view, demonstrating successful rescue at cellular level." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341237_Fig6_panel0.png,"Toluidine blue staining of mast cells in the meninges of sham, TBI/vehicle, and TBI/IMMA treated mice. Arrows indicate degranulated mast cells with faint staining." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341237_Fig6_panel1.png,"Total mast cell density in the meninges of sham, TBI/vehicle, and TBI/IMMA treated mice. Both TBI groups show an increase compared to sham, but IMMA treatment reduces this increase." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341237_Fig6_panel2.png,"Degranulated mast cell density in the meninges of sham, TBI/vehicle, and TBI/IMMA treated mice. TBI/vehicle shows a significant increase over sham, which is reduced by IMMA treatment." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341249_Fig2_panel0.png,"Heidelberg optical coherence tomography (OCT) image of the patient’s right eye (OD), showing significant thinning of the retinal layers." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341249_Fig2_panel1.png,"Heidelberg optical coherence tomography (OCT) image of the patient’s left eye (OS), showing significant thinning of the retinal layers." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341300_Fig2_panel0.png,ACT slices from public datasets showing lung regions with various highlighted areas for analysis. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341300_Fig2_panel1.png,"Representative CT slices of four pneumoconiosis subtypes, with yellow bounding boxes indicating model predictions and blue boxes denoting ground truth annotations." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341300_Fig2_panel2.png,"3D pulmonary reconstructions following YOLOX-based boxes extraction, showcasing different stages or types of lung conditions." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341325_Fig1_panel0.png,"A Color Doppler mapping of internal carotid artery, anterior cerebral artery, and pericallosal artery in the midsagittal plane." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341325_Fig1_panel1.png,B Pulsed-wave Doppler acquisition of the anterior cerebral artery showing waveform analysis. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341342_Fig2_panel0.png,Preoperative sagittal CT image showing the spine from T1 to T8. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341342_Fig2_panel1.png,Preoperative sagittal MR image highlighting the spinal cord and surrounding structures. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341342_Fig2_panel2.png,Another preoperative sagittal MR image providing a different view of the spine. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341342_Fig2_panel3.png,Postoperative sagittal CT image demonstrating the results of TCAF surgery. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341342_Fig2_panel4.png,Postoperative sagittal MR image showing changes after the surgical procedure. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341342_Fig2_panel5.png,Additional postoperative sagittal MR image illustrating further details of the spine. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341342_Fig2_panel6.png,Preoperative axial CT image at a specific vertebral level. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341342_Fig2_panel7.png,Preoperative axial CT image at another vertebral level. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341342_Fig2_panel8.png,Preoperative axial MR image showing cross-sectional details of the spine. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341342_Fig2_panel9.png,Postoperative axial CT image indicating changes after surgery. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341342_Fig2_panel10.png,Another postoperative axial CT image at a different vertebral level. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341342_Fig2_panel11.png,Postoperative axial MR image demonstrating the outcome of the surgical intervention. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341348_f3-inj-2550118-059_panel0.png,"Immunostaining of Iba-1 expression in the cortex for young, aging, and aging+exercise groups. The merge shows the combined lectin and Iba-1 staining." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341348_f3-inj-2550118-059_panel1.png,"Immunostaining of GFAP expression in the hippocampal CA1 region for young, aging, and aging+exercise groups. The merge shows the combined lectin and GFAP staining." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341348_f3-inj-2550118-059_panel2.png,"Comparison of Iba-1 and GFAP expression between young, aging, and aging+exercise groups in the cortex and hippocampal CA1 region." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341348_f3-inj-2550118-059_panel3.png,"Quantitative analysis showing the percentage area of Iba-1 and GFAP expression in young, aging, and aging+exercise groups, indicating the effect of exercise on reducing activation." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341370_F2_panel0.png,"Complementation strategy of SAG1 into the UPRT locus. An antibody against SAG1 (green) confirms complementation, while DAPI stain (blue) shows the nuclear DNA." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341370_F2_panel1.png,"Mean reduction in lysis plaque area for infections of naive HFFs versus HFFs pre-stimulated with 2 µM 25HC or 10 units/mL IFNγ, and comparison between regular and delipidated sera for WT, Δsag1, and Δsag1::SAG1 strains." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341370_F2_panel2.png,"Percentage reduction in the number of lysis plaques formed in HFFs stimulated with IFNγ, treated with 25HC, or cultured in delipidated serum compared to naive HFFs in regular serum for the indicated strains." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341371_F2_panel0.png,"Representative BLI of mice infected with Ig::Tn and icmQ::Tn strains at D0, D1, D2, and D3 post-infection." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341371_F2_panel1.png,Total flux (photons/s) of infected mice over days post-infection for Ig::Tn and icmQ::Tn strains. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341371_F2_panel2.png,"Representative BLI of ex vivo organs (spleen, liver, and adipose) for Ig::Tn and icmQ::Tn strains." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341371_F2_panel3.png,"Total flux (photons/s) of ex vivo organs (spleen, liver, and adipose) at day 3 post-infection." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341371_F2_panel4.png,"Organ weight as a percentage of total body weight on day 3 post-infection for spleen, liver, and adipose." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341371_F2_panel5.png,"Genome equivalents extracted from organs (spleen, liver, and adipose) at day 3 post-infection." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341371_F2_panel6.png,IL-6 levels (pg/mL) in serum and peritoneal lavage fluid (PLF) at day 3 post-infection. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341371_F2_panel7.png,IL-10 levels (pg/mL) in serum and PLF at day 3 post-infection. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341487_jms5161-fig-0001_panel0.png,"MALDI-IHC of Aβ(1-42) plaques shows a distribution with varying intensities, highlighting the outer regions of the plaques." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341487_jms5161-fig-0001_panel1.png,MALDI-IHC of Aβ(1-16) plaques reveals a different pattern with higher intensity in the inner regions compared to Aβ(1-42). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341487_jms5161-fig-0001_panel2.png,"Overlaid images of Aβ(1-42) and Aβ(1-16) demonstrate the disparity between the outer and inner regions of the plaques, emphasizing intra-plaque heterogeneity." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341534_fig1_panel0.png,"(1A) CAPSULaer. Anterior lens capsule with cauterized margin (long arrow), epithelial cells (E) with elongated nuclei (short arrow), and lens fiber (F). H&E, x400." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341534_fig1_panel1.png,"(1B) CCC. Anterior capsule with a sharp edge (long arrow) and epithelial cells (short arrow). H&E, x400." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341534_fig1_panel2.png,"(1C) CAPSULaser. The maximum thickness of the attached lens fiber tissue measuring 237.1 μm. H&E, x400." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341534_fig1_panel3.png,"(1D) CAPSULaser. The tissue edge with the cauterized length measuring 62.12 μm. H&E, x400." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341534_fig1_panel4.png,"(1E) CAPSULaser. Cauterized capsule (C) with a bubbly appearance (short arrows) and hole-like areas (long arrows). Uranyl acetate, lead citrate, x10,000." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341534_fig1_panel5.png,"(1F) CAPSULaser. The cauterized area showing electron-dense amorphous material (white arrows) obscuring the underlying structures (asterisks). Uranyl acetate, lead citrate, x6,000." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341603_fig0001_panel0.png,"Electron microscope image showing detailed surface texture of a cinnamon particle with measurements D1 = 10.3 nm, D2 = 11.9 nm, and D3 = 9.4 nm." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341682_uaaf038-F7_panel0.png,Axial view showing a well-defined ovoid lesion in the midline within the splenium of the corpus callosum. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341682_uaaf038-F7_panel1.png,Axial view highlighting the lesion's location within the splenium of the corpus callosum and bilateral thalami. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341682_uaaf038-F7_panel2.png,Axial view demonstrating high signal intensity on T2-weighted imaging within the lesion. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341682_uaaf038-F7_panel3.png,Axial view showing the lesion with no enhancement on postcontrast sequence. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341682_uaaf038-F7_panel4.png,Axial view revealing mild restricted diffusion on DWI/ADC sequence within the lesion. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341682_uaaf038-F7_panel5.png,Axial view confirming the lesion's characteristics on FLAIR imaging. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341684_tqaf096-F3_panel0.png,"In axial CTA image A, the saddle-shaped carotid body tumour is shown at its largest size, with density-1 and standard deviation measurements." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341684_tqaf096-F3_panel1.png,"In axial CTA image B, the saddle-shaped carotid body tumour is shown at the level of peak contrast enhancement, with density-2 measurements." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341684_tqaf096-F3_panel2.png,"In axial CTA image C, the ipsilateral common carotid artery density is measured, providing a reference for normalizing the tumour density measurements." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341692_fig3_panel0.png,Right superficial femoral artery (SFA) aneurysm (A) as seen on a CT scan at the time of presentation. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341692_fig3_panel1.png,Right superficial femoral artery (SFA) aneurysm (B) during open surgical repair after the first round of chemotherapy. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341822_acel70111-fig-0002_panel0.png,"H&E-stained sections of human ovarian cortex and medulla explants cultured for 6 days with 24 h doxorubicin exposure (0 or 0.1 μg/mL). Histology at Day 0, uncultured tissues is shown for comparison." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341822_acel70111-fig-0002_panel1.png,"H&E-stained sections of human ovarian cortex and medulla explants cultured for 10 days with 24 h doxorubicin exposure (0 or 0.1 μg/mL). Histology at Day 0, uncultured tissues is shown for comparison." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341822_acel70111-fig-0002_panel2.png,Immunohistochemistry for CC3 in the ovarian cortex and medulla explants on day 6 of culture showing low levels of cellular apoptosis (pvalue > 0.05). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341822_acel70111-fig-0002_panel3.png,"Glucose levels measured in conditioned media of the cultured cortex and medulla explants on Days 0, 1, 3, 5, and 6, showing decreasing glucose levels in conditioned media, indicating glucose consumption by explants throughout 6 days of culture." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341822_acel70111-fig-0002_panel4.png,Immunohistochemistry for CC3 in the ovarian cortex and medulla explants on Day 10 of culture showing low levels of cellular apoptosis (pvalue > 0.05). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341822_acel70111-fig-0002_panel5.png,"Glucose levels measured in conditioned media of the cultured cortex and medulla explants on Days 0, 1, 3, 5, 7, 9, and 10, showing decreasing glucose levels in conditioned media, indicating glucose consumption by explants throughout 10 days of culture." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341836_f0001_panel0.png,Angiography of the celiac trunk reveals multiple pseudoaneurysms located in the two-thirds of the spleen (white arrows). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341836_f0001_panel1.png,The patient underwent coil embolization of the proximal splenic artery (black arrow) to reduce blood flow to the splenic parenchymal lesions. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341858_f2_panel0.png,Intraoperative picture (a) showing contamination and associated inflammatory adhesions in the left upper quadrant. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341858_f2_panel1.png,Intraoperative picture (b) showing contamination and associated inflammatory adhesions in the right upper quadrant. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341858_f2_panel2.png,Intraoperative picture (c) demonstrating the antral perforation. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12341858_f2_panel3.png,Intraoperative picture (d) showing the tip of the Maryland dissector inserted into the perforation to assist with identification for endoscopic closure. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342126_F6_panel0.png,GFAP positivity in the retinal layers at the 24th hour after treatment with 50 mg/kg MNU and 50 mg/kg minocycline. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342126_F6_panel1.png,PCNA positivity in the retinal layers at the 24th hour after treatment with 50 mg/kg MNU and 50 mg/kg minocycline. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342126_F6_panel2.png,GFAP positivity in the retinal layers at the 72nd hour after treatment with 50 mg/kg MNU and 50 mg/kg minocycline. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342126_F6_panel3.png,PCNA positivity in the retinal layers at the 72nd hour after treatment with 50 mg/kg MNU and 50 mg/kg minocycline. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342126_F6_panel4.png,GFAP positivity in the retinal layers at the 7th day after treatment with 50 mg/kg MNU and 50 mg/kg minocycline. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342126_F6_panel5.png,PCNA positivity in the retinal layers at the 7th day after treatment with 50 mg/kg MNU and 50 mg/kg minocycline. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342193_lungindia.lungindia_515_24-F1_panel0.png,Chest X-ray showing massive left pleural effusion (White arrow). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342193_lungindia.lungindia_515_24-F1_panel1.png,Post ICD insertion chest X-ray. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342204_lungindia.lungindia_459_24-F3_panel0.png,"A single long extracted twig, approximately 23 cm in length, lies on a blue textured surface next to a transparent ruler for scale." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342356_dgae899-F3_panel0.png,"ORO staining in TED and NON-TED OFs over time, showing lipid accumulation during adipogenesis." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342356_dgae899-F3_panel1.png,"mRNA expression of FABP4 in TED and NON-TED OFs over time, indicating gene expression changes during adipogenesis." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342356_dgae899-F3_panel2.png,"Representative ORO staining of TED OFs in differentiation medium on day 12, showing lipid droplet formation." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342356_dgae899-F3_panel3.png,"Representative ORO staining of NON-TED OFs in differentiation medium on day 12, showing minimal lipid droplet formation." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342356_dgae899-F3_panel4.png,"Representative ORO staining of TED OFs in differentiation medium with Yoda1 treatment on day 12, showing altered lipid droplet formation." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342356_dgae899-F3_panel5.png,"Representative ORO staining of NON-TED OFs in differentiation medium with Yoda1 treatment on day 12, showing minimal lipid droplet formation." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342360_f1_panel0.png,"Sagittal slice of a CT scan showing a radiotherapy treatment plan with delineation of the primary tumor using blue for CTV, yellow for GTV, and green for PTV, along with red highlighting for metastatic abdominal lymph nodes." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342599_qyaf087-F1_panel0.png,Transthoracic echocardiogram parasternal long-axis view demonstrating aortic valve regurgitation with vena contracta measuring 6.3 mm. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342599_qyaf087-F1_panel1.png,Transthoracic echocardiogram parasternal short-axis view showing four leaflets of the aortic valve. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342599_qyaf087-F1_panel2.png,Real-time 3D transoesophageal echocardiogram view depicting the aortic valve with three leaflets. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342599_qyaf087-F1_panel3.png,CT scan of the heart in short-axis view illustrating the presence of four leaflets. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342599_qyaf087-F1_panel4.png,CT scan demonstrating the distance from the ostium to coronary arteries during pre-procedural planning. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342599_qyaf087-F1_panel5.png,Transthoracic echocardiogram parasternal long-axis view showing optimal positioning of TAVR post-implantation. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342599_qyaf087-F1_panel6.png,Transthoracic echocardiogram apical long-axis view with Doppler ultrasound confirming favorable results following TAVR procedure. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342599_qyaf087-F1_panel7.png,Fluoroscopic image depicting successful TAVR implantation. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342679_f1-cpcem-9-352_panel0.png,"A close-up view of a patient's right occipital scalp showing a non-tender, two-centimeter pulsatile mass marked by a yellow circle with an arrowhead, accompanied by overlying erythema." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342684_F6_panel0.png,Schematic representation of the critical defect model used for studying in vivo wound healing effects of Zn-Gel. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342684_F6_panel1.png,"Digital images showing mouse skin defect models at days 0, 7, and 14 post-treatment with Z0 and Z0.5." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342684_F6_panel2.png,Quantitative analysis of wound closure percentage over time for Z0 and Z0.5 treatments. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342684_F6_panel3.png,Immunohistochemistry staining and quantification for Ki67 at day 7 and day 14 for Z0 and Z0.5 treatments. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342684_F6_panel4.png,Quantification of Ki67-positive cells percentage at day 7 and day 14 for Z0 and Z0.5 treatments. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342684_F6_panel5.png,"Immunohistochemistry staining and quantification for CD31 at day 7 and day 14 for Z0 and Z0.5 treatments, indicating blood vessel structures." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342684_F6_panel6.png,Quantification of vessel number at day 7 and day 14 for Z0 and Z0.5 treatments. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342684_F6_panel7.png,"Immunohistochemistry staining and quantification for cytokeratin 19 at day 7 and day 14 for Z0 and Z0.5 treatments, indicating hair follicle formation." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342684_F6_panel8.png,Quantification of hair follicle number at day 7 and day 14 for Z0 and Z0.5 treatments. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342697_F2_panel0.png,Stereomicroscopy image of kidney organoids under control conditions showing normal tubular structure. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342697_F2_panel1.png,Stereomicroscopy image of kidney organoids exposed to Beni-koji CholesteHelp (100 μg/mL) showing significant tubular thinning (red arrows). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342697_F2_panel2.png,Stereomicroscopy image of kidney organoids exposed to cisplatin (60 μm) showing significant tubular thinning (red arrows). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342697_F2_panel3.png,H&E stained section of control kidney organoids showing normal cellular structure. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342697_F2_panel4.png,H&E stained section of kidney organoids exposed to Beni-koji CholesteHelp showing luminal accumulation. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342697_F2_panel5.png,H&E stained section of kidney organoids exposed to cisplatin showing luminal accumulation. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342697_F2_panel6.png,H&E stained section of control kidney organoids showing normal tubular structure. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342697_F2_panel7.png,"H&E stained section of kidney organoids exposed to Beni-koji CholesteHelp showing tubular cell thinning (black arrows), structural disruption (white arrows), and luminal accumulation (arrowheads)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342697_F2_panel8.png,"H&E stained section of kidney organoids exposed to cisplatin showing tubular cell thinning (black arrows), structural disruption (white arrows), and luminal accumulation (arrowheads)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342785_ytaf367-F3_panel0.png,Enface view of the mechanical tricuspid valve with a single 10 mm balloon inflated in the anterior orifice. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342785_ytaf367-F3_panel1.png,Enface view of the mechanical tricuspid valve with two 6 mm balloons inflated side by side in the anterior orifice. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342785_ytaf367-F3_panel2.png,Enface view of the mechanical tricuspid valve with a 6 mm balloon and an 8 mm balloon inflated side by side in the anterior orifice. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342817_f3_panel0.png,(A) Thyroid gland on low power H + E (4×) photomicrograph showing a representative section of unremarkable thyroid gland. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342817_f3_panel1.png,(B) Thyroid gland calcitonin stain (20×) image showing the thyroid proper is negative for calcitonin. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342817_f3_panel2.png,(C) Left level 4 lymph node with low power H + E (4×) photomicrograph demonstrating a lateral neck node replaced by tumor with a paraganglioma-like appearance. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342817_f3_panel3.png,(D) Left level 6 lymph node with low power H + E (4×) photomicrograph demonstrating a central neck node replaced by tumor with a classic medullary thyroid carcinoma appearance. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342841_FIG2_panel0.png,Atypical spermatic cord lipoma case showing thickened fibrous septae with increased cellularity under low-power magnification (H&E; 10×). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342841_FIG2_panel1.png,Atypical spermatic cord lipoma case demonstrating stromal nuclear atypia with variation in nuclear size and occasional hyperchromasia under high-power magnification (H&E; 40×). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342841_FIG2_panel2.png,Well-differentiated liposarcoma case showing variably cellular fibrous septae under low-power magnification (H&E; 10×). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342841_FIG2_panel3.png,Well-differentiated liposarcoma case demonstrating stromal atypia under high-power magnification (H&E; 40×). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342899_f1_panel0.png,Histology of transected superficial radial nerve involved by CLL. Panel A: HE stain showing multifocal lymphocytic infiltrates (arrows; ×40 magnification). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342899_f1_panel1.png,Histology of transected superficial radial nerve involved by CLL. Panel B: HE stain showing multifocal lymphocytic infiltrates (×100 magnification). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342899_f1_panel2.png,Panel C: Immunohistochemistry (IHC) for neurofilament reveals mild reduction of axons (×100 magnification). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342899_f1_panel3.png,Panel D: IHC for CD20 highlights predominant B-cell component of perivenular infiltrates (×100 magnification). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342899_f1_panel4.png,Panel E: IHC for CD20 highlights predominant B-cell component of perivenular infiltrates (×200 magnification). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342899_f1_panel5.png,Panel F: IHC for CD3 shows scanty positive cells compatible with reactive T-cells (×200 magnification). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342899_f1_panel6.png,Panel G: IHC reveals weak to moderate CD5 positivity in the majority of B-cells (×200 magnification) with coexpression of CD23. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342915_ytaf363-F1_panel0.png,"Transoesophageal echocardiography (TOE) showing a large thrombus (2.5 × 1.3 cm) located in the left atrial appendage (LAA), with labels for the left atrium (LA) and left ventricle (LV)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342989_f1_panel0.png,"A map highlighting sample locations within Laikipia County, Isiolo County, and Samburu County, including specific areas like Lower Imenti Forest Reserve and Samburu National Reserve." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342999_ytaf359-F1_panel0.png,Panel (A)—electrocardiogram showing diffuse low voltage QRS complexes and pseudoinfarct pattern in anterior precordial leads. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342999_ytaf359-F1_panel1.png,"Panel (B)—Echocardiography still image showing hypertrophied left ventricular walls with a granular sparkling appearance, thickened interatrial septum with biatrial dilatation and a thin rim of pericardial effusion." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342999_ytaf359-F1_panel2.png,Panel (C)—Pulsed wave Doppler across the mitral valve showing E/A ratio of 3.86 suggesting grade III diastolic dysfunction. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342999_ytaf359-F1_panel3.png,Panel (D)—Cherry-on-top pattern of global longitudinal strain with reduction in basal segments and apical sparing. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342999_ytaf359-F1_panel4.png,Panel (E)—Cardiac MRI showing diffuse subendocardial late gadolinium enhancement (white arrow). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12342999_ytaf359-F1_panel5.png,Panel (F)—Abdominal fat pad biopsy showing apple-green birefringence (asterisk) on polarization light microscopy after Congo Red staining. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343055_FIG1_panel0.png,"Contrast-enhanced CT image obtained before chemotherapy demonstrating a large soft tissue mass (107 × 77 × 151 mm) originating from the left kidney, with invasion into the inferior vena cava (IVC) and left psoas major muscle." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343055_FIG1_panel1.png,"Contrast-enhanced CT image obtained after chemotherapy showing a reduction in tumor size (59 × 56 × 101 mm), but psoas muscle invasion remained." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343065_f2_panel0.png,"TEE image showing two leaks from the Inspiris Resilia valve post second aortic cross-clamp removal. A larger, broad-based, moderate or greater regurgitant leak is visible at the non/right commissure (indicated by the long arrow), alongside a new mild leak along the left/right commissure (indicated by the short arrow)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343165_fig6_panel0.png,Initial ultrasound image showing a single neovessel at the insertional aspect of the superficial right Achilles tendon in a 20-year-old female beach volleyball athlete. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343165_fig6_panel1.png,"Ultrasound image of the same tendon taken 1 year later, showing changes or progression from the initial condition." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343229_f1_panel0.png,INFa (expansive): tumor nests with expansive growth and well-defined borders with surrounding tissues. The scale bar represents 200μm. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343229_f1_panel1.png,INFb (intermediate): intermediate growth pattern between INFa and INFc. The scale bar represents 200μm. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343229_f1_panel2.png,INFc: tumor nests with infiltrative growth and unclear borders with surrounding tissues. The scale bar represents 1mm. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343252_f4_panel0.png,Appearance of rat spleen and liver under different conditions. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343252_f4_panel1.png,Rat liver tissue pathological changes observed with H&E staining at 100× and 400× magnification. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343252_f4_panel2.png,Ishak score for rat liver fibrosis across different groups. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343252_f4_panel3.png,Observation of liver fibrosis in rats with Masson’s Trichrome staining at 100× and 400× magnification. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343252_f4_panel4.png,Comparison of the area of Masson’s Trichrome staining in rat liver across different groups. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343327_jcmm70777-fig-0004_panel0.png,"F-Actin ring staining of BMMs treated with RANKL alone or with Ski at different concentrations, showing the effect on actin ring formation." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343327_jcmm70777-fig-0004_panel1.png,Bar graph showing the proportion of osteoclasts with F-Actin rings after treatment with RANKL and varying concentrations of Ski. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343327_jcmm70777-fig-0004_panel2.png,"Acridine orange staining of BMMs treated with RANKL alone or with Ski, illustrating the effect on acid secretion in osteoclasts." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343327_jcmm70777-fig-0004_panel3.png,"Graph showing the fluorescence intensity ratio of red to green light, indicating the impact of Ski on acid vesicle function in osteoclasts." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343352_fig1_panel0.png,Representative photograph showing a full-cortex bone defect (0.5 cm in length) created in the shaft of ulna. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343352_fig1_panel1.png,Representative radiographic image of forearm showing the defect of ulna stabilized with a titanium plate and three screws on each side of the defect. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343352_fig1_panel2.png,Postsurgical photograph of fiberglass cast on the forearm. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343355_fig5_panel0.png,Completion angiography shows widely patent bilateral iliac limbs with complete exclusion of the aneurysm sac. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343358_fig2_panel0.png,"Mcl-1 protein expression changes relative to baseline across different dose levels of VOR on days D1, D3, and D14." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343358_fig2_panel1.png,Mcl-1 protein expression changes over time during VOR administration at various dose levels from D3 to D14. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343358_fig2_panel2.png,"Change in Mcl-1 expression by clinical response categories (PD, SD, MLFS/CRh/CRI) at different time points during VOR treatment." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343365_FIG2_panel0.png,"Low-power image of the left iliac bone biopsy (H&E stain) showing trabecular bone and bone marrow with multiple granulomas (arrows) surrounded by fibrosis. Scale bar = 200 µm, 5X magnification." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343365_FIG2_panel1.png,"High-power image showing well-formed non-necrotizing granulomas (arrows) with surrounding lymphoplasmacytic inflammation, characteristic of sarcoidosis. Scale bar = 50 µm, 20X magnification." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343367_Fig1_panel0.png,"Primary care physicians' perceived impact of CMS E/M guideline changes on the time and effort spent documenting various aspects of patient care. The chart shows responses for 'History of Present Illness/Physical Exam,' 'Review of Systems,' and 'Assessment & Plan.'" |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343374_Fig2_panel0.png,Comparison of true values vs. predictions for ejection fractions. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343374_Fig2_panel1.png,Violin plot showing the distribution of model error. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343374_Fig2_panel2.png,Histogram depicting the distribution of errors. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343374_Fig2_panel3.png,Plot of error values across different samples. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343374_Fig2_panel4.png,Autocorrelation plot of the residuals. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343374_Fig2_panel5.png,Partial autocorrelation plot of the residuals. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343378_Fig1_panel0.png,The original medical image showing a cross-section of the chest. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343378_Fig1_panel1.png,"The medical image after being augmented by zooming, focusing on the central area of the chest." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343378_Fig1_panel2.png,"The medical image after being augmented by rotation, altering its orientation while maintaining the chest cross-section view." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343494_F3_panel0.png,Preoperative ultrasound evaluation showing the heart before the procedure. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343494_F3_panel1.png,"Postoperative TTE reexamination demonstrating optimal placement of the occluder, no residual shunt, and no new onset of aortic or tricuspid regurgitation." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343692_Fig9_panel0.png,aFinal restoration showing a close-up view of the restored teeth. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343692_Fig9_panel1.png,bFinal restoration X-Ray displaying the internal structure of the restored tooth. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343692_Fig9_panel2.png,c1 year follow-up showing the maintained condition of the restored teeth after a year. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343732_F4_panel0.png,Coronal View of FODs estimated by the MLP using the full dHCP dataset. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343732_F4_panel1.png,Coronal View of FODs estimated by the sCNN using 30% of the diffusion directions. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343732_F4_panel2.png,Coronal View of Ground truth FODs estimated using Hybrid-CSD with the full dHCP dataset. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343732_F4_panel3.png,Sagittal View of FODs estimated by the MLP using the full dHCP dataset. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343732_F4_panel4.png,Sagittal View of FODs estimated by the sCNN using 30% of the diffusion directions. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343732_F4_panel5.png,Sagittal View of Ground truth FODs estimated using Hybrid-CSD with the full dHCP dataset. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343732_F4_panel6.png,Axial View of FODs estimated by the MLP using the full dHCP dataset. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343732_F4_panel7.png,Axial View of FODs estimated by the sCNN using 30% of the diffusion directions. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343732_F4_panel8.png,Axial View of Ground truth FODs estimated using Hybrid-CSD with the full dHCP dataset. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343762_Fig7_panel0.png,The proliferation ability of Saos-2 and U2OS cells was assessed using the CCK-8 assay after coculturing them with exosomes isolated from SCAMP1-AS1/LKB1-silenced OS cells. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343762_Fig7_panel1.png,EdU staining images and quantification of EdU-positive cells for Saos-2 and U2OS cells after coculturing with exosomes isolated from SCAMP1-AS1/LKB1-silenced OS cells. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343762_Fig7_panel2.png,Transwell migration assay images and quantification of migrated Saos-2 and U2OS cells after coculturing with exosomes isolated from SCAMP1-AS1/LKB1-silenced OS cells. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343762_Fig7_panel3.png,Transwell invasion assay images and quantification of invaded Saos-2 and U2OS cells after coculturing with exosomes isolated from SCAMP1-AS1/LKB1-silenced OS cells. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343848_Fig16_panel0.png,Control group showing baseline migration of A549 cells. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343848_Fig16_panel1.png,Overexpression of GPER1 (GPER1-oe) increases the migration of A549 cells. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343848_Fig16_panel2.png,Knockdown of GPER1 (GPER1-sh) decreases the migration of A549 cells. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343848_Fig16_panel3.png,Knockdown of GPER1 combined with Y27632 treatment further reduces the migration of A549 cells. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343848_Fig16_panel4.png,Bar graph showing statistical significance of migrated A549 cells across different treatments. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343977_bju16770-fig-0001_panel0.png,PSMA PET/CT fusion imaging identifies eligibility for robot-assisted RGS. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343977_bju16770-fig-0001_panel1.png,Preoperative [99mTc]Tc-PSMA-I&S single-photon emission CT/CT fusion imaging cross-validates tracer uptake. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343977_bju16770-fig-0001_panel2.png,Trocar placement diagram for surgical access during the procedure. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343977_bju16770-fig-0001_panel3.png,In vivo assessment of local recurrence localization and extension using a drop-in gamma-probe. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343977_bju16770-fig-0001_panel4.png,Ex vivo measurements confirm the removal of cancerous tissue using a gamma-probe. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12343977_bju16770-fig-0001_panel5.png,Systematic scanning of the resection bed verifies no residual cancer tissue. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344026_Fig2_panel0.png,[18F]DOPA PET axial slice showing a CHI focus in the head of the pancreas (indicated by the black arrow). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344026_Fig2_panel1.png,[68Ga]Exendin PET axial slice highlighting a CHI focus (indicated by the black arrow). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344026_Fig2_panel2.png,[18F]DOPA PET/MRI fused image showing the CHI focus in the pancreas (indicated by the white arrow). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344026_Fig2_panel3.png,[68Ga]Exendin PET/MRI fused image displaying the CHI focus (indicated by the white arrow). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344147_Fig3_panel0.png,"Case 1 shows fragments incidentally found in a blue shark's eye during histological processing, with a ruler for scale." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344147_Fig3_panel1.png,"Case 3 displays a single fragment from a blue shark, with a 1 cm scale bar for reference." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344147_Fig3_panel2.png,"Case 4a presents two fragments placed on a photographic tray, with a grid background for scale." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344147_Fig3_panel3.png,"Case 4b shows a fragment embedded within the tissue of a blue shark, with a 1 cm scale bar for reference." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344147_Fig3_panel4.png,Case 5 features a single fragment with a yellow measuring tape for scale. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344147_Fig3_panel5.png,Case 6 displays multiple fragments arranged on a grid background. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344147_Fig3_panel6.png,"Case 7 shows several fragments on a white background, with a checkered pattern at the bottom." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344147_Fig3_panel7.png,Case 8 presents multiple fragments on a white background with a checkered pattern at the top. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344147_Fig3_panel8.png,Case 9 displays several fragments on a gray surface with a color-coded scale bar. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344147_Fig3_panel9.png,Case 10 shows a single fragment on a gray surface with a color-coded scale bar. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344217_dvdy722-fig-0002_panel0.png,"Nodal1 expression in the vegetal hemisphere, bottle cells, and suprablastoporal endoderm at stage 10." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344217_dvdy722-fig-0002_panel1.png,Transverse section showing Nodal1 expression in bottle cells and suprablastoporal endoderm at stage 10. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344217_dvdy722-fig-0002_panel2.png,"Sox17 expression in the vegetal hemisphere, bottle cells, and suprablastoporal endoderm at stage 10." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344217_dvdy722-fig-0002_panel3.png,Transverse section showing Sox17 expression in bottle cells and suprablastoporal endoderm at stage 10. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344217_dvdy722-fig-0002_panel4.png,Foxj1 expression in the superficial mesoderm at stage 10. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344217_dvdy722-fig-0002_panel5.png,Transverse section showing Foxj1 expression in the superficial mesoderm at stage 10. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344217_dvdy722-fig-0002_panel6.png,Lefty expression in the deep mesoderm at stage 10. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344217_dvdy722-fig-0002_panel7.png,Transverse section showing Lefty expression in the deep mesoderm at stage 10. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344218_vsu14274-fig-0001_panel0.png,Postoperative ventrodorsal radiograph (A) showing a 12 mm BFX acetabular cup placed in a lateralized position. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344218_vsu14274-fig-0001_panel1.png,Postoperative ventrodorsal radiograph (B) showing a 12 mm BFX acetabular cup placed in a lateralized position. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344218_vsu14274-fig-0001_panel2.png,Postoperative ventrodorsal radiograph (C) showing the acetabular cup placed more medially with involvement of the medial acetabular wall. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344218_vsu14274-fig-0001_panel3.png,Postoperative ventrodorsal radiograph (D) showing the acetabular cup placed more medially with involvement of the medial acetabular wall. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344224_vsu14275-fig-0001_panel0.png,"X-ray showing standardized measurement points for femoral cortical thickness along the femur, including immediately distal to the lesser trochanter, one-quarter of the way down, and halfway down the femur." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344248_fig4_panel0.png,"Surgical photomicrograph displaying broad anastomosing cords and sheets of bland basaloid to squamoid cells with adjacent calcifications indicated by an arrow (hematoxylin-eosin, 10×)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344251_fig4_panel0.png,T2 FLAIR image showing a white matter lesion with hypointensity. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344251_fig4_panel1.png,T1-weighted image displaying a lesion with hypointensity. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344251_fig4_panel2.png,CBF map highlighting the lesion area with altered cerebral blood flow. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344251_fig4_panel3.png,OEF map showing increased oxygen extraction fraction in the lesion region. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344301_fig_005_panel0.png,Macroscopic view of the C5 spinal cord segment showing a cross-section with a scale bar indicating measurements. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344301_fig_005_panel1.png,"Histopathological evaluation of the C5 spinal cord section under weak magnification, revealing structural abnormalities." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344301_fig_005_panel2.png,Strong magnification of the C5 spinal cord section highlighting spheroid formations (arrowheads) indicative of Wallerian degeneration. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344301_fig_005_panel3.png,Macroscopic view of the T3 spinal cord segment displaying a cross-section with a scale bar for reference. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344301_fig_005_panel4.png,Weak magnification histopathological examination of the T3 spinal cord section showing extensive myelomalacia. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344301_fig_005_panel5.png,Strong magnification of the T3 spinal cord section illustrating severe pathological changes and hemorrhage. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344301_fig_005_panel6.png,Macroscopic view of the L3 spinal cord segment with a scale bar for size comparison. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344301_fig_005_panel7.png,Weak magnification histopathological analysis of the L3 spinal cord section demonstrating severe diffuse hemorrhage. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344301_fig_005_panel8.png,Strong magnification of the L3 spinal cord section revealing thrombi in the meninges and spinal cord parenchyma blood vessels. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344315_fig_001_panel0.png,"Image of testis from Cheetah 1, showing the organ with an attached epididymis." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344315_fig_001_panel1.png,"Image of testis from Cheetah 2, displaying the organ with some discoloration and an attached epididymis." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344315_fig_001_panel2.png,"Image of testis from Cheetah 3, where the epididymis has been removed, leaving only the main part of the testis." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344415_luaf156-F3_panel0.png,Graves’ acropachy showing fusiform swelling of the hand before treatment. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344415_luaf156-F3_panel1.png,Improved appearance of the hand after teprotumumab treatment. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344415_luaf156-F3_panel2.png,X-ray of hands showing soft tissue swelling and extensive bilateral periostitis and subperiosteal bone formation indicated by arrows in multiple metacarpals and phalanges. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344416_qyaf099-F2_panel0.png,"Demarcation of the region of interest in an IVF patient without recurrent VA (A) by tracking the endocardial border in an apical two-chamber projection. The myocardium is divided into six segments, and the global longitudinal strain is -25.4%." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344416_qyaf099-F2_panel1.png,"Demarcation of the region of interest in an IVF patient with recurrent VA (B) by tracking the endocardial border in an apical two-chamber projection. The myocardium is divided into six segments, and the global longitudinal strain is -14.9%." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344416_qyaf099-F2_panel2.png,"The corresponding longitudinal strain curves for an IVF patient without recurrent VA (C). The strain curves are color-coded to match the segments, showing the peak systolic longitudinal strain (-21.7%), time to longitudinal strain peak (403-420 ms), and post-systolic shortening (34 ms)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344416_qyaf099-F2_panel3.png,"The corresponding longitudinal strain curves for an IVF patient with recurrent VA (D). The strain curves are color-coded to match the segments, showing the peak systolic longitudinal strain (-16%), time to longitudinal strain peak (435-552 ms), and post-systolic shortening (117 ms)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel0.png,Transverse section of petiole pulvinus from the new Derris sample showing cellular structure. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel1.png,Transverse section of petiole from the new Derris sample displaying tissue organization. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel2.png,Transverse section of rachis from the new Derris sample illustrating internal anatomy. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel3.png,Transverse section of petiolule pulvinus from the new Derris sample highlighting structural details. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel4.png,Transverse section of midrib from the new Derris sample showing vascular bundles. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel5.png,Transverse section of leaf blade from the new Derris sample demonstrating cell arrangement. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel6.png,Transverse section of leaf margin from the new Derris sample revealing edge characteristics. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel7.png,Transverse section of petiole pulvinus from D. solorioides showing cellular structure. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel8.png,Transverse section of petiole from D. solorioides displaying tissue organization. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel9.png,Transverse section of rachis from D. solorioides illustrating internal anatomy. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel10.png,Transverse section of petiolule pulvinus from D. solorioides highlighting structural details. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel11.png,Transverse section of midrib from D. solorioides showing vascular bundles. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel12.png,Transverse section of leaf blade from D. solorioides demonstrating cell arrangement. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel13.png,Transverse section of leaf margin from D. solorioides revealing edge characteristics. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344443_F2_panel14.png,Transverse section of leaf blade from D. solorioides focusing on druse crystals. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344549_msaf173-F1_panel0.png,"A field of annual water hyacinths (Eichhornia paniculata) from Northeastern Brazil, showcasing their natural habitat and floral diversity." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344549_msaf173-F1_panel1.png,"A close-up view of the flowers of Eichhornia paniculata, highlighting the intricate details of the petals and reproductive structures." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344549_msaf173-F1_panel2.png,"A diagram illustrating the three forms of tristyly in Eichhornia paniculata: long-styled (L), mid-styled (M), and short-styled (S), along with their genetic combinations." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344554_f1-ce-2024-330_panel0.png,A large submucosal tumor visible under white-light imaging. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344554_f1-ce-2024-330_panel1.png,A mucosal defect at the apex highlighted with indigo carmine dye. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344554_f1-ce-2024-330_panel2.png,Initial stage of liposarcoma resection using endoscopic submucosal dissection. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344554_f1-ce-2024-330_panel3.png,Progression of liposarcoma resection showing tissue removal. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344554_f1-ce-2024-330_panel4.png,Further stages of liposarcoma resection with more tissue excised. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344554_f1-ce-2024-330_panel5.png,Final view after successful resection of the liposarcoma. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344610_FIG2_panel0.png,HE 20x staining of a typical carcinoid tumor showing cellular structure. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344610_FIG2_panel1.png,Chromogranin A staining highlighting positive areas in a typical carcinoid tumor. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344610_FIG2_panel2.png,CD56 staining indicating positive regions in a typical carcinoid tumor. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344628_adhm202401136-fig-0006_panel0.png,"CellTox Green assay results showing cell death percentage over time when exposed to VEGF-A, PLX4720, and PLX4032." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344628_adhm202401136-fig-0006_panel1.png,Quantification of CLSM imaging data representing cell death percentages after drug exposure. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344628_adhm202401136-fig-0006_panel2.png,"Mean gray values of the melanoma models after 7 days of drug exposure, indicating changes in cellular activity." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344628_adhm202401136-fig-0006_panel3.png,"Maximum intensity projections of a 3D melanoma model after 7 days of exposure to different drugs, visualized with various cell markers." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344628_adhm202401136-fig-0006_panel4.png,"3D reconstructions of SERS mappings for VEGF-A treated samples, showing labeled cells with distinct markers over 7 days." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344659_fig1_panel0.png,Comparison of spectral power in the Gamma2 band between the Migraine Group and HC Group across various brain regions. Each row shows a specific brain region with bar graphs indicating normalized power for both groups and brain images highlighting areas of interest. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344676_F0002_panel0.png,"Relative WBC and lymphocyte levels in control, HQ, and HQ & MMF groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344676_F0002_panel1.png,"Western blot analysis of p-β-catenin, β-catenin, and GAPDH in control, HQ, and HQ & MMF groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344676_F0002_panel2.png,"Levels of p-β-catenin and β-catenin in control, HQ, and HQ & MMF groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344676_F0002_panel3.png,"H&E staining showing lymphocyte infiltration in control, HQ, and HQ & MMF groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344676_F0002_panel4.png,"Western blot analysis of p-GSK3β, GSK3β, and GAPDH in control, HQ, and HQ & MMF groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344676_F0002_panel5.png,"Levels of p-GSK3β and GSK3β in control, HQ, and HQ & MMF groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344676_F0002_panel6.png,"Relative mRNA levels of Ascl2, Dct, and Dct2 in control, HQ, and HQ & MMF groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344676_F0002_panel7.png,"Relative mRNA levels of TGF-β and IFN-γ in control, HQ, and HQ & MMF groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344684_F0001_panel0.png,Statistics of body weight over time for different treatment groups (n=10). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344684_F0001_panel1.png,Statistics of kidney weight for different treatment groups (n=10). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344684_F0001_panel2.png,Statistics of blood urea nitrogen (BUN) in serum for different treatment groups (n=10). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344684_F0001_panel3.png,Statistics of creatinine (Cr) in serum for different treatment groups (n=10). |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344684_F0001_panel4.png,"Representative images of HE staining of kidney tissue for different treatment groups (n=10), showing histological changes." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344684_F0001_panel5.png,"Representative images of TNF-α staining of kidney tissue for different treatment groups (n=5), showing inflammatory response." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344706_fig3_panel0.png,"ICol-MA after swelling in acetic acid solution as part of the methacrylation reaction. The banding pattern is clearly visible, indicated by the white arrow." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344706_fig3_panel1.png,ICol-MA after swelling in DMSO and subsequent washing and drying. The banding pattern is no longer visible. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344706_fig3_panel2.png,ICol-MA after swelling in DMSO/HCl and subsequent washing and drying. There is no observable banding pattern. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344707_F0005_panel0.png,"Expression of MPO in the renal sections of Control, Sham, I/R, and I/R+Ro groups as observed by IHC analysis." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344707_F0005_panel1.png,Renal MPO activity measurements for various treatment groups using a commercial kit. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344707_F0005_panel2.png,MPO and Cit-H3 protein levels in renal tissue detected by Western Blot analysis for different treatment groups. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344711_fig2_panel0.png,Shear rate sweep from 0.01 to 10 s–1 displaying viscosity differences between ionically cross-linked Diluent PA and RG PA nanofiber samples. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344711_fig2_panel1.png,Dynamic strain sweep from 0.01 to 100% determining the linear viscoelastic regime (LVR) for G' and G'' of Diluent PA and RG PA nanofiber samples. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344711_fig2_panel2.png,Frequency sweep at fixed strain determining the elastic modulus (G') for G' and G'' of Diluent PA and RG PA nanofiber samples. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344711_fig2_panel3.png,Scanning electron microscopy (SEM) image highlighting the topography of diluent PA nanofibers with a scale bar of 10 μm. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344711_fig2_panel4.png,Scanning electron microscopy (SEM) image highlighting the topography of RG PA nanofibers with a scale bar of 10 μm. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344783_fig0001_panel0.png,bFFE 3DVaneXD SPAIR image at FA: 20°. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344783_fig0001_panel1.png,bFFE 3DVaneXD SPAIR image at FA: 50°. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344783_fig0001_panel2.png,bFFE 3DVaneXD SPAIR image at FA: 80°. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344783_fig0001_panel3.png,T1 3DVaneXD mDixon (water) image at FA: 5°. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344783_fig0001_panel4.png,T1 3DVaneXD mDixon (water) image at FA: 10°. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344783_fig0001_panel5.png,T1 3DVaneXD mDixon (water) image at FA: 20°. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344897_Fig2_panel0.png,"Bodyweight distribution of female Yorkshire Terriers over age, showing a median trend line." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344897_Fig2_panel1.png,"Bodyweight distribution of male Yorkshire Terriers over age, showing a median trend line." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344929_Fig1_panel0.png,Preoperative anteroposterior and lateral radiographs showing severe HO formation (red arrowhead) in the elbow. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344929_Fig1_panel1.png,"The patient with 75% burn area, lying on an operating table." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344929_Fig1_panel2.png,Large HO and scar tissue visible during surgery (green triangle) around the elbow joint. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344929_Fig1_panel3.png,Postoperative radiographs showing thorough removal of HO and application of HEF in the elbow. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344933_Fig1_panel0.png,Angioedema of the lips in patient 1 |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344933_Fig1_panel1.png,Angioedema of the lips in patient 2 |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344974_f0025_panel0.png,Panel a: Postoperative echocardiography showing measurements and flow patterns related to the ascending aorta. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344974_f0025_panel1.png,Panel b: Postoperative echocardiography displaying additional measurements and flow dynamics of the ascending aorta. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344974_f0025_panel2.png,Panel c: Postoperative echocardiography illustrating the conduit at the ascending aorta with color-coded flow visualization. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12344974_f0025_panel3.png,Panel d: Postoperative echocardiography highlighting the conduit at the ascending aorta with detailed flow patterns and measurements. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345028_Fig1_panel0.png,Shoulder arthroscopy under controlled hypotension – a close-up view of a surgical instrument inserting a staple into tissue. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345039_Fig2_panel0.png,Schematic diagram of the establishment of the CIS-induced AKI mouse model and DM-AKG treatment. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345039_Fig2_panel1.png,"Scr levels in mouse serum for CON, CIS-AKI, and CIS-AKI + DM-AKG groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345039_Fig2_panel2.png,"BUN levels in mouse serum for CON, CIS-AKI, and CIS-AKI + DM-AKG groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345039_Fig2_panel3.png,"H&E staining showing histologic changes in mouse kidneys for CON, CIS-AKI, and CIS-AKI + DM-AKG groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345039_Fig2_panel4.png,"Tubular injury scores for CON, CIS-AKI, and CIS-AKI + DM-AKG groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345039_Fig2_panel5.png,"Western blot analysis detecting KIM-1 and Caspase-3 protein expression in CON, CIS-AKI, and CIS-AKI + DM-AKG groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345039_Fig2_panel6.png,"Optical density of KIM-1 normalized to GAPDH for CON, CIS-AKI, and CIS-AKI + DM-AKG groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345039_Fig2_panel7.png,"Optical density of Caspase-3 normalized to GAPDH for CON, CIS-AKI, and CIS-AKI + DM-AKG groups." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345084_Fig1_panel0.png,Identification of the recurrent laryngeal nerve at the inferior margin of the thyroid gland. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345084_Fig1_panel1.png,Identification of the recurrent laryngeal nerve. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345084_Fig1_panel2.png,Identification of the inferior parathyroid gland. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345084_Fig1_panel3.png,The superior border of the thyroid gland was dissociated upward to identify the superior parathyroid gland. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345084_Fig1_panel4.png,Dissection of the central lymph nodes. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345084_Fig1_panel5.png,Indocyanine green fluorescence was used to assess the blood supply of the parathyroid gland. The anatomical site marked by the arrows and circles is the parathyroid gland. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345102_Fig1_panel0.png,"Example of the operational environment for healthcare personnel, highlighting the course layout and densely populated grandstands." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345102_Fig1_panel1.png,"Customized golf cart equipped to function as an advanced medical response vehicle, enabling rapid on-site interventions." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345102_Fig1_panel2.png,Interior view of the observation and treatment area within the main field hospital. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345102_Fig1_panel3.png,"Illustration of a targeted health risk mitigation strategy—during the 6:00 AM gate opening, large crowds rushing to secure optimal viewing spots created a significant risk of falls and trauma. Dedicated medical teams were strategically positioned along high-risk pathways immediately prior to gate opening to provide prompt assistance." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345205_F1_panel0.png,"Detection of cellular cholesterol levels in IPI-2I and Vero E6 cells following SADS-CoV infection at 12, 24, and 36 hpi. Fliplin stains intracellular cholesterol (blue), SADS-CoV N proteins are stained green, and cell nuclei are labeled red." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345205_F1_panel1.png,"Quantification of cholesterol levels in SADS-CoV-infected cells compared to mock-infected cells, measured by blue fluorescence intensity using ImageJ software." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345205_F1_panel2.png,"Total cholesterol levels in duodenum, jejunum, and ileum tissues from SADS-CoV-infected and mock-infected piglets, determined using a total cholesterol detection kit." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345205_F1_panel3.png,"Representative microphotographs of viral antigen immunochemical staining in SADS-CoV-infected and non-infected small intestine tissues (duodenum, jejunum, and ileum) using an antibody against the SADS-CoV N protein." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345313_f0040_panel0.png,"Velocity contour with pressure magnitude on velocity vector showing drop breakage via two collapsing cavities under ΔP of 1x10^6 Pa at σ_dc=0.03N/m, μ_d=0.005Pa.s, and β=2.5." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345313_f0040_panel1.png,"Velocity contour with pressure magnitude on velocity vector showing drop breakage via two collapsing cavities under ΔP of 5x10^6 Pa at σ_dc=0.03N/m, μ_d=0.005Pa.s, and β=2.5." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345313_f0040_panel2.png,"Velocity contour with pressure magnitude on velocity vector showing drop breakage via two collapsing cavities under ΔP of 1x10^7 Pa at σ_dc=0.03N/m, μ_d=0.005Pa.s, and β=2.5." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345389_cyt70003-fig-0001_panel0.png,"Sheet of somewhat monomorphic epithelioid cells on the left transitioning to highly pleomorphic cells with increased mitotic activity on the right, showing granular and eosinophilic cytoplasm and a delicate capillary network (H&E, 20× magnification)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345389_cyt70003-fig-0001_panel1.png,"Strong staining for synaptophysin in the tumor cells (Immunohistochemistry, 20× magnification)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345389_cyt70003-fig-0001_panel2.png,"Diffuse nuclear staining for GATA3 in the tumor cells (Immunohistochemistry, 20× magnification)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345389_cyt70003-fig-0001_panel3.png,"Strong cytoplasmic staining for chromogranin in the tumor cells (Immunohistochemistry, 20× magnification)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345389_cyt70003-fig-0001_panel4.png,"Diffuse expression of SDHB in the tumor cells (Immunohistochemistry, 20× magnification)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345389_cyt70003-fig-0001_panel5.png,"Ki-67 index showing up to nearly 80% in the hot spot area of the tumor (Immunohistochemistry, 20× magnification)." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345567_animals-15-02179-f003_panel0.png,Negative control section from the duodenum showing no IAP staining due to absence of the primary antibody. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345567_animals-15-02179-f003_panel1.png,Negative group section from the duodenum of healthy pigs showing minimal IAP staining. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345567_animals-15-02179-f003_panel2.png,Positive group section from the duodenum of pigs infected with Escherichia coli showing increased IAP staining on the apical membrane of villous enterocytes. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345567_animals-15-02179-f003_panel3.png,Negative control section from the jejunum showing no IAP staining due to absence of the primary antibody. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345567_animals-15-02179-f003_panel4.png,Negative group section from the jejunum of healthy pigs showing minimal IAP staining. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345567_animals-15-02179-f003_panel5.png,Positive group section from the jejunum of pigs infected with Escherichia coli showing increased IAP staining on the apical membrane of villous enterocytes. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345567_animals-15-02179-f003_panel6.png,Negative control section from the ileum showing no IAP staining due to absence of the primary antibody. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345567_animals-15-02179-f003_panel7.png,Negative group section from the ileum of healthy pigs showing minimal IAP staining. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345567_animals-15-02179-f003_panel8.png,Positive group section from the ileum of pigs infected with Escherichia coli showing increased IAP staining on the apical membrane of villous enterocytes. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345643_cancers-17-02422-f006_panel0.png,"Schematic representation of the correlation workflow, showing histology-derived clusters matched to imaging-derived clusters based on optimized permutations of cluster area and tumor habitat volume." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345643_cancers-17-02422-f006_panel1.png,"Scatter plots depicting significant positive linear correlations between the percent tumor volume of Clusters 2, 4, and 5 in the central MRI slice and the corresponding percent tumor area in histological cross-sections." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345647_foods-14-02553-f002_panel0.png,Scanning electron micrograph of a control sausage sample showing its microstructure. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345647_foods-14-02553-f002_panel1.png,"Scanning electron micrograph of a sausage sample with 7% EG formulation, illustrating microstructural changes." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345647_foods-14-02553-f002_panel2.png,"Scanning electron micrograph of a sausage sample with 10% EG formulation, highlighting further microstructural modifications." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345708_cells-14-01159-f002_panel0.png,THP-1 macrophages (MϕFPR+/+) in RPMI medium showing FITC (green) and rhodamine phalloidin (red) staining. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345708_cells-14-01159-f002_panel1.png,THP-1 macrophages (MϕFPR+/+) treated with CTX (12.5 nM) showing FITC (green) and rhodamine phalloidin (red) staining. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345708_cells-14-01159-f002_panel2.png,THP-1 macrophages (MϕFPRs−/−) in RPMI medium showing FITC (green) and rhodamine phalloidin (red) staining. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345708_cells-14-01159-f002_panel3.png,THP-1 macrophages (MϕFPRs−/−) treated with CTX (12.5 nM) showing FITC (green) and rhodamine phalloidin (red) staining. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345708_cells-14-01159-f002_panel4.png,THP-1 macrophages (MϕFPR+/+) stimulated with fMLP showing FITC (green) and rhodamine phalloidin (red) staining. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345708_cells-14-01159-f002_panel5.png,THP-1 macrophages (MϕFPR+/+) stimulated with fMLP and treated with CTX showing FITC (green) and rhodamine phalloidin (red) staining. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345759_ijms-26-07086-f003_panel0.png,Experimental protocol for the efficacy study of TM5441 in CSE-induced COPD model mice. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345759_ijms-26-07086-f003_panel1.png,"Representative images of HE-stained lung tissue at magnification ×100: (a) PBS without TM5441, (b) PBS with TM5441, (c) CSE without TM5441, (d) CSE with TM5441." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345759_ijms-26-07086-f003_panel2.png,MLI and DI measurements in mice after intratracheal administration of PBS or CSE and oral gavage of vehicle or TM5441. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345759_ijms-26-07086-f003_panel3.png,RI and Cdyn values in mice after intratracheal administration of PBS or CSE and oral gavage of vehicle or TM5441. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345825_diagnostics-15-01956-f002_panel0.png,Transvaginal ultrasound showing a cervical pregnancy with the gestational sac located in the cervix. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345825_diagnostics-15-01956-f002_panel1.png,Ultrasound confirmation of a fetal heart rate in the case of a cervical pregnancy. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345825_diagnostics-15-01956-f002_panel2.png,"Initial aortography showing blood supply to the gestational sac originating from the uterine arteries, with no collateral flow from the ovarian arteries." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345825_diagnostics-15-01956-f002_panel3.png,Selective catheterization of the uterine arteries during the embolization procedure. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345825_diagnostics-15-01956-f002_panel4.png,Embolization of the uterine arteries using methotrexate and gelfoam to stop blood flow to the gestational sac. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345825_diagnostics-15-01956-f002_panel5.png,Final angiography confirming no blood flow to the gestational sac after embolization. |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345858_cancers-17-02480-f001_panel0.png,"A non-treated PA-1 cell nucleus labeled as (A), showing distinct regions of heterochromatin (red) and euchromatin (green), with corresponding fluorescence intensity curves." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345858_cancers-17-02480-f001_panel1.png,"Fluorescence intensity graph for the non-treated cell nucleus (A), displaying the relationship between heterochromatin, euchromatin, and DAPI intensity along a specified line." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345858_cancers-17-02480-f001_panel2.png,"An ETO-treated PA-1 cell nucleus labeled as (B), showing intermingled heterochromatin (red) and euchromatin (green) regions, with a corresponding fluorescence intensity profile." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345858_cancers-17-02480-f001_panel3.png,"Fluorescence intensity graph for the ETO-treated cell nucleus (B), illustrating the overlap and intermingling of heterochromatin and euchromatin intensities along a specified line." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345885_f0005_panel0.png,"Chest radiograph (AP, supine) of a three-month-old male infant showing a right parenchymal opacity that obscures the right costophrenic angle." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345903_healthcare-13-01838-f003_panel0.png,"Macroscopic image of the specimen after surgical excision, with longitudinal measurement of the neuroma using a millimeter scale." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345903_healthcare-13-01838-f003_panel1.png,"Radiofrequency application using an active needle positioned directly on the neuroma. The metallic background corresponds to the return plate of the generator, which was required to complete the electrical circuit and enable thermal transmission during the ablation process." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345959_cells-14-01168-f001_panel0.png,"A study flow of NC administration, behavioral, histological, and molecular assays over weeks -1 to 5-6." |
| /home2020/home/icube/kunyuan/biomedica_fg_data/images_300k/raw_data/eval_biomedica_images_2025/splited_panel/pmc_image_PMC12345959_cells-14-01168-f001_panel1.png,"Low power fluorescence (GFAP/DAPI) image showing the anatomical regions studied in the histological analysis of β-amyloid deposition and GFAP, including the cortex, hippocampus, and thalamus regions." |
| |
